Come up with a name for your new list and we'll add to it:
SYNTARGA B.V. raised a round of funding on April 01, 2005. Investors include
Aglaia Biomedical Ventures.
Syntarga is a biopharmaceutical company creating chemistries to link anticancer activity to specificity. The company develops releasable linker technologies and potent linker-drug combinations for co…